NO20032206D0 - Combination therapy for estrogen-dependent disorders - Google Patents

Combination therapy for estrogen-dependent disorders

Info

Publication number
NO20032206D0
NO20032206D0 NO20032206A NO20032206A NO20032206D0 NO 20032206 D0 NO20032206 D0 NO 20032206D0 NO 20032206 A NO20032206 A NO 20032206A NO 20032206 A NO20032206 A NO 20032206A NO 20032206 D0 NO20032206 D0 NO 20032206D0
Authority
NO
Norway
Prior art keywords
estrogen
combination therapy
dependent disorders
disorders
dependent
Prior art date
Application number
NO20032206A
Other languages
Norwegian (no)
Other versions
NO20032206L (en
Inventor
Dinesh Purandare
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20032206D0 publication Critical patent/NO20032206D0/en
Publication of NO20032206L publication Critical patent/NO20032206L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20032206A 2000-11-16 2003-05-15 Combination therapy for estrogen-dependent disorders NO20032206L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71460500A 2000-11-16 2000-11-16
PCT/US2001/043847 WO2002039995A2 (en) 2000-11-16 2001-11-06 Combination therapy for estrogen-dependent disorders

Publications (2)

Publication Number Publication Date
NO20032206D0 true NO20032206D0 (en) 2003-05-15
NO20032206L NO20032206L (en) 2003-07-15

Family

ID=24870727

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032206A NO20032206L (en) 2000-11-16 2003-05-15 Combination therapy for estrogen-dependent disorders

Country Status (16)

Country Link
EP (1) EP1341549A2 (en)
JP (1) JP2004536022A (en)
KR (1) KR20030051828A (en)
CN (1) CN1498112A (en)
AU (1) AU2002230464A1 (en)
BR (1) BR0115423A (en)
CA (1) CA2428249A1 (en)
CZ (1) CZ20031349A3 (en)
EA (1) EA200300572A1 (en)
IL (1) IL155817A0 (en)
MX (1) MXPA03004195A (en)
NO (1) NO20032206L (en)
NZ (1) NZ525720A (en)
PL (1) PL365904A1 (en)
WO (1) WO2002039995A2 (en)
ZA (1) ZA200303669B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
GB0506759D0 (en) * 2005-04-02 2005-05-11 Medical Res Council Combination treatment methods
EP1891964A1 (en) * 2006-08-08 2008-02-27 AEterna Zentaris GmbH Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
JP2010524996A (en) * 2007-04-23 2010-07-22 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Combination of progesterone receptor antagonists with lutein hormone releasing hormone agonists and antagonists for use in BRCA mediated diseases
CN101775054B (en) * 2010-02-05 2012-12-26 常州佳尔科药业集团有限公司 Synthesis method of 4-hydroxyl-4-alkene-3-ketone steroide compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911582D0 (en) * 1999-05-18 1999-07-21 Pharmacia & Upjohn Spa Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia

Also Published As

Publication number Publication date
WO2002039995A9 (en) 2003-02-06
EA200300572A1 (en) 2004-06-24
NO20032206L (en) 2003-07-15
NZ525720A (en) 2006-12-22
MXPA03004195A (en) 2003-09-22
WO2002039995A2 (en) 2002-05-23
AU2002230464A1 (en) 2002-05-27
IL155817A0 (en) 2003-12-23
WO2002039995A3 (en) 2003-05-01
ZA200303669B (en) 2004-05-13
PL365904A1 (en) 2005-01-10
EP1341549A2 (en) 2003-09-10
CN1498112A (en) 2004-05-19
BR0115423A (en) 2005-12-13
CZ20031349A3 (en) 2004-05-12
CA2428249A1 (en) 2002-05-23
JP2004536022A (en) 2004-12-02
KR20030051828A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
NO20021329D0 (en) Kinase inhibitors as therapeutic agents
DK1637127T3 (en) THERAPEUTIC MICROSUM
DE69924365D1 (en) MASSAGER
IS7236A (en) Therapeutic isoquinoline compounds
NO20004688D0 (en) Therapy for estrogen-associated disorders
DE60130237D1 (en) LASER THERAPY DEVICE
DK1303521T3 (en) Tetra Hydro-heterocycloazepinyl-pyrimidine
NO20022692D0 (en) Therapeutic agents
NO20033205L (en) Therapeutic kroman compounds
DE60208982D1 (en) footbath
DE60009451D1 (en) massager
FI20002177A0 (en) New combination for asthma therapy
NO20032206L (en) Combination therapy for estrogen-dependent disorders
NO20016301D0 (en) Therapeutic agents
DOP2001000232A (en) THERAPEUTIC COMBINATION
SE0103854D0 (en) Therapeutic agents
SE0103855D0 (en) Therapeutic agents
SE0004826D0 (en) Therapeutic compounds
SE0003368D0 (en) Therapeutic compounds
SE0004825D0 (en) Therapeutic compounds
DE10193217D2 (en) therapy device
ITBO20000651A0 (en) DISPENSER FOR MUD THERAPY
SE0100008D0 (en) Therapeutic compounds
SE0100006D0 (en) Therapeutic compounds
SE0100009D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application